Mazdutide (10mg)

$77.00

1 Unit
$77 per unit
$77.00
2 Units
$75.08 per unit (save 2% per unit)
$150.16
$154.00
3 Units
$73.15 per unit (save 5% per unit)
$219.45
$231.00
4 Units
$71.23 per unit (save 7% per unit)
$284.92
$308.00
5 Units
$69.3 per unit (save 10% per unit)
$346.50
$385.00
6 Units
$67.38 per unit (save 12% per unit)
$404.28
$462.00
7 Units
$65.45 per unit (save 15% per unit)
$458.15
$539.00
8 Units
$63.53 per unit (save 17% per unit)
$508.24
$616.00
9 Units
$61.6 per unit (save 20% per unit)
$554.40
$693.00
10 Units
$59.68 per unit (save 22% per unit)
$596.80
$770.00
Category:

Description

Mazdutide is a dual agonist peptide that activates both the GLP-1 receptor and glucagon receptor, offering multiple metabolic and physiological benefits:

Significant weight loss: In clinical trials, participants lost 11–14% of body weight over 48 weeks, with higher doses showing even greater results.
Improved blood sugar control: Mazdutide reduces HbA1c levels and enhances insulin sensitivity, outperforming semaglutide in head-to-head trials for both glucose control and weight loss in patients with type 2 diabetes.
Reduced liver fat: In studies, mazdutide reduced liver fat by up to 80.2% in patients with metabolic dysfunction-associated fatty liver disease (MAFLD), with 70% achieving normal liver fat levels after 48 weeks.
Cardiometabolic improvements: It lowers blood pressure, improves cholesterol and triglyceride levels, reduces waist circumference, and decreases serum uric acid and liver enzymes.
Enhanced energy expenditure: Glucagon receptor activation increases fat burning and energy use, supporting sustained weight loss.
Neuroprotective effects: Emerging research suggests mazdutide may mitigate cognitive dysfunction associated with obesity and type 2 diabetes.
Bone health and kidney function: It may reduce bone breakdown and increase sodium excretion, contributing to improved bone and cardiovascular health.
Mazdutide is approved in China under the brand name Xinermei for weight management and type 2 diabetes, with ongoing global trials evaluating its use in conditions like obstructive sleep apnea, heart failure, and alcohol use disorder.

Related products